Inventor · Port Hope, ON, CA

Andrew Roughton

11Patents
2h-index
25Co-inventors
50Inventor score

Filing activity: Feb 2, 2007 → Jun 8, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7989459B2 Purinones and 1H-imidazopyridinones as PKC-theta inhibitors Human Necessities 4 Active
US10981921B2 Fragment synthesis of substituted cyclic peptides Emerging Cross-Sectional Technologies 3 Active
US11072616B2 Cyclic peptides targeting alpha-4-beta-7 integrin Emerging Cross-Sectional Technologies 2 Active
US11046695B2 Fragment synthesis of substituted cyclic peptides Emerging Cross-Sectional Technologies 2 Active
US11111273B2 Cyclic peptides multimers targeting alpha-4-beta-7 integrin Emerging Cross-Sectional Technologies 2 Active
US8211927B2 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators Chemistry; Metallurgy 2 Active
US11713338B2 Cyclic peptides multimers targeting α-4-β-7 integrin Emerging Cross-Sectional Technologies 1 Active
US8314091B2 N-benzyl,N'-arylcarbonylpiperazine derivatives Chemistry; Metallurgy 0 Active
US12077611B2 Cyclic peptides multimers targeting α4β7 integrin Emerging Cross-Sectional Technologies 0 Active
US11286281B2 Homodetic cyclic peptides targeting alpha-4-beta-7 integrin Emerging Cross-Sectional Technologies 0 Active
US8759352B2 1-(4-ureidobenzoyl)piperazine derivatives Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.